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IT has long been recognised that tumours differ in their energy metabolism
from normal tissues. Despite considerable investigation it is still not clear
whether the altered energy metabolism is causally related to tumour development
or merely secondary to the malignant state, although attempts to solve this
problem have not been lacking (Weinhouse, 1955; Warburg, 1956; Weber, 1963).
In this laboratory, we have been interested in three pyridine nucleotide-linked
dehydrogenases, one from each of the principal pathways of glucose catabolism.
The present status of each in relation to cancer biochemistry will be briefly
reviewed.
Lactate dehydrogenase (EC 1. 1.1.27) LDH
This enzyme catalyses the reversible reduction of pyruvate to lactate, the
final step in anaerobic glycolysis. The product is known to accumulate in high
concentration in many tumours (de Roetth, 1957; McBeth and Bekesi, 1962), and
increased serum LDH activity is a feature of many tumour-bearing animals and
human cancer patients (Wroblewski, 1958; 1959). Several reports point to
increased LDH activity in tumours of animals (Rees and Huggins, 1960; Weber,
Banerjee, Levine and Ashmore, 1961; di Simone, Lorenzutti and Sapie, 1962;
Mori, Niyaji, Murata and Nagasuna, 1962; Thiery and Willighagen, 1964;
Hershey, Johnston, Murphy and Schmitt, 1966) and of man (Ames, Albaum and
Antopol, 1964; Goldman, Kaplan and Hall, 1964; Shonk, Arison, Koven,
Majima and Boxer, 1965). In rat hepatomas, on the other hand, LDH activity
may be unchanged or diminished (Weber and Cantero, 1959; Boxer and Shonk,
1960; Weber, Banerjee and Morris, 1961; Jones, 1965; Hoch-Ligeti, Stutzman,
Grantham, Brown and Arvin, 1966) and studies with tumours of various strains
have failed to show a correlation between the growth rate of the tumours and
their LDH content (Weber and Morris, 1963; Shonk, Morris and Boxer, 1965).
Isocitrate dehydrogenase (EC 1. 1. 1.42) (ICDH)
The oxidation of isocitrate to oxalosuccinate is carried out by this enzyme
which occupies an important position in the tricarboxylic acid cycle. Early
work by Warburg, recapitulated in more recent publications, suggested that this
cycle is defective in most tumours (Warburg, 1956), but this viewhasbeen strongly
contested (Weinhouse, 1955). Activity ofICDH was increased in murine cervical
cancers (Thiery and Willighagen, 1964) and in rat mammary cancers (Hilf, Michel,HEATHER A. AYRE AND D. M. GOLDBERG
Bell, Freeman and Borman, 1965; Hershey et al., 1966), but there seems to be a
dearth of data concerning ICDH in human tumours.
Phosphogluconate dehydrogenase (EC 1. 1. 1.44) (PGDH)
The oxidative decarboxylation of6-phosphogluconate to ribulose-5-phosphate,
the second step in the hexose monophosphate shunt, is catalysed by this enzyme.
Operation of this pathway is enhanced in tumours as compared with normal
tissues (Abraham, Hill and Chaikoff, 1955; Kit, 1956) although its contribution
to glucose catabolism is farbelowthat ofglycolysis (WennerandWeinhouse, 1956).
Studies by Weber and his associates have failed to reveal significantly increased
activity of PGDH during induction of Rous sarcomata (Weber et al., 1961), nor
could its activity be correlated with the growth rate of hepatomata (Weber and
Morris, 1963). Low activity has been reported in a histochemical examination of
a rat hepatoma (Jones, 1965). Other investigators have found this enzyme to be
raised in proliferating cells of various types (Fitch and Chaikoff, 1960; Chayen,
Bitensky, Aves, Jones, Silcox and Cunningham, 1962), and a link with cell
hyperplasia has also been suggested (Scott, Morris, Reiskin and Pakoskey, 1962).
The present work describes our findings in comparing the.activities of these
enzymes in malignant and non-malignant samples of human cervix uteri.
MATERIALS AND METHODS
Fifteen samples ofnon-malignant and 23 ofmalignant cervix uteri drawn from
the material of our previous report (Goldberg and Pitts, 1966) were employed in
this study, the tissues being separated into cytoplasmic fractions as described in
that report. Enzyme estimations were carried out as follows:
LDH.-The method of Neilands (1955) was used to measure the activity of
this enzyme at 250 C., additional buffer bringing the volume to 3*0 ml., with the
substrate 0-48 M instead of 0 5 M as in the original. The test cuvette contained
0.1 ml. 0.02 M-NAD+ (freshly prepared), 0.1 ml. 0.48 M-sodium lactate, and 2.7 ml.
0.1M-glycine buffer, pH 10-0. The blank comprised 0-1 ml. 0.02 M-NAD+ and
2*8 ml. glycine buffer. 0.1 ml. of test material, suitably diluted, was added to
each cuvette and the change in extinction at 340 m#s was measured at minute
intervals over a 10-minute period. The mean extinction change per minute was
converted to m,uMoles NADH formed/min./ml. material on multiplying by the
factor 4*83.
ICDH.-The method ofPlaut and Sung (1954) was used to measure the activity
of this enzyme at 250 C., additional buffer replacing distilled water as prescribed
in the original. The test cuvette contained 0*2 ml. 0*0015 m-NADP+ (sodium salt,
freshlyprepared), 0.1 ml. 0-02 M-MnSO4, 0*05 ml. 0-08 M-dl-isocitric acid (trisodium
salt) and 2-55 ml. 0-1 M-Tris buffer, pH 7*4. The substrate was omitted from the
blank which contained 2-60 ml. Tris buffer. 0-1 ml. of test material, suitably
diluted, was added to each cuvette and the activityexpressed as m,uMolesNADPH
formed/min./ml. material was calculated exactly as for the previous enzyme.
PGDH.-The method of Horecker and Smyrniotis (1955) was modified by
substituting buffer for distilled water, and the reaction was carried out at 250 C.
The test cuvette contained 0-2 ml. 0.02 M-MgCl2, 0.2 ml. 0*0015 M-NADP+ (freshly
prepared), 0*2 ml. 0*25 m-6-phosphogluconic acid, trisodium salt, and 2-2 ml.
0-025 M-glycylglycine/NaCl buffer, pH 7*4. Substrate was omitted from the
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blank which contained 2.4 ml. buffer. 0*1 ml. of test material, suitably diluted,
was added to each cuvette, and the change in extinction at 340 m,t was measured
at minute intervals for 10 minutes. The mean extinction change per minute was
converted to m,uMoles NADPH formed/min./ml. material on multiplying by the
factor 4-67.
Protein concentration was measured by the method of Lowry, Rosebrough,
Farr and Randall (1951).
RESULTS
In all samples of normal cervix uteri, the pattern of enzyme activity was
LDH > ICDH > PGDH. This pattern was followed by all but 4 of the cancers
in which the order was LDH > PGDH > ICDH. The mean specific activities
of all the dehydrogenases were higher in the supernatant fraction of the cancer
specimens than in the corresponding fraction of the normal samples (Table I).
The difference in specific activity ofLDH between the two groups was not signifi-
cant, and as may be seen from Fig. 1 the range of individual values overlapped.
The mean specific activity of supernatant ICDH was elevated in the cancer group
to a level 50%0 above the mean for the normal group (Table I) and this difference
was statistically significant although individual values lay within the same range
in both groups (Fig. 1). The mean supernatant PGDH specific activity of the
cancer group was almost threefold that of the normal group, and two-thirds of
the individual values in the cancer group exceeded the highest value found in the
normal group.
When enzyme activity was related to tissue weight, the differences between
normal and cancer groups were enhanced, as would be expected from our previous
demonstration of increased supernatant protein concentration in cancer of the
cervix uteri (Goldberg and Pitts, 1966). Although the mean LDH activity ofthe
cancer group was, on this basis, more than twice that ofthe normal group (Table I)
the difference was not significant, and only 5 cancer specimens exceeded the
highest LDH activity recorded in the normal group (Fig. 1). The mean ICDH
activity ofthe cancer supernatants per g. wet weight was likewise more than twice
that of the normal group (Table I), but since the variance was much less than
with the previous enzyme, the difference was highly significant. This may be
verified graphically by reference to Fig. 1 which shows that almost two-thirds of
the cancer specimens exceeded the highest activity recorded in the normal series.
Even more striking was the five-fold increase in the mean supernatant PGDH
activity per g. wet weight in the cancer group over that of the normal group; in
TABLE I.-Dehydrogenase Activities in Supernatant Fraction of
Normal and Malignant Cervix Uteri.
Mean+S.E. of 15 normals and 23 cancers. All activities as m,um substrate
transformed/min. per mg. protein or per g. wet weight at 25°.
Units/mg. protein Units/g. wet weight
Normal Cancer t P Normal Cancer t P
LDH 102±10 140±25 1-14 N.S.* 2900±420 6860-- 1550 1-92 N.S.*
ICDH 24-6±2-4 36-7±3-5 2-44 <0-02 . 690±80 1820±210 4 03 <0 001
PGDH . 11-2±1-5 29-0±4-6 2-92 <0-01 210±35 1120±110 6-14 <0.001
* Not Significant
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FIG. 1.-Enzyme activities of supernatant fraction in relation to tissue weight (left) and
protein concentration (right) in individual samples of non-malignant (solid circles) and
malignant (open circles) human cervix uteri. Abbreviations as in text.
keeping with a difference of this magnitude, only 4 of the cancer specimens fell
within the range of individual values given by the normal group. Careful study
of the data did not reveal any clear correlation between enzyme activity and the
degree of malignancy as assessed clinically and histologically according to the
criteria described in our previous report (Goldberg and Pitts, 1966).
Particulate fractions obtained from samples of normal cervix were adequate
for analysis in about halfthe samples, but the activity ofthe dehydrogenases was
so weak as to be virtually indistinguishable from zero. The need to preserve
optical clarity ofthe solutionsimposedobvious limitations onthe assayofundiluted
preparations. With this qualification, we therefore conclude that in normal
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cervix uteri, all three dehydrogenases studied are confined to the supernatant
By contrast, reliable data were obtained from most ofthe cancers and are presented
in Table II. The activities of the dehydrogenases were fairly similar in the mito-
chondrial and microsomal fractions. Only two differences require comment.
The specific activity of microsomal LDH was nearly three-fold that of the mito-
chondrial enzyme (t = 2-58; P < 0-02). Although the ICDH content of the
microsomal fraction relative to tissue weight was almost twice that of the mito-
chondrial fraction, this difference was not significant (t = 1.99).
The activities of the two particle fractions are, by weight, very low compared
with those ofthe supernatant, and do not account for more than a small percentage
of the total cytoplasmic activities (Table III). Moreover, the activities relative
to protein are, with the exception of microsomal LDH, less than 10% that of the
corresponding activity for the supernatant fraction.
TABLE II. Dehydrogenase Activities in Mitochondrial and Microsomal Fractions
of Malignant Cervix Uteri
Mean±S.E. of 15 samples. All activities as m,tM substrate transformed/
min. per mg. protein or per g. wet weight at 25°.
Units/mg. protein Units/g. wet weight
r - A
Alitochondria Microsomes Mitochondria Microsomes
LDH 14-4±3-6 37-892 132±34 205±56
ICDH 2-7±0-4 2-7±0-4 . 22-7±49 35-4±6-1
PGDH 1-3±0-4 2 1±0 5 15-6±5-0 19-4±5-2
TABLE III. Distribution of Dehydrogenases among Cytoplasmic Fractions
of Malignant Cervix Uteri
MeanAS.E. per cent total cytoplasmic activity of each fraction based on
15 samples.
Supernatant Mitochondria Microsomes
LDH . 95-3±2-6 1-80-2 2-90-3
ICDH . 96-9±2-4 1-2+0-1 1-90-02
PGDH . 96-9±1-9 . 1-40-1 1-7±0-2
DISCUSSION
The supernatant activity
In our previous communication (Goldberg and Pitts, 1966), we have presented
data which demonstrate that cancers of the cervix uteri possess increased ability
to degrade nucleic acids, and speculated that this difference was too great to be
due to sampling error and dilution ofepithelial with non-epithelial elements in the
normal specimens. The same cannot be said with confidence ofthe three dehydro-
genases.
LDH activity was not significantly increased, possibly because the level is
already rather high in normal cervix in line with the high lactic acid concentration
of normal vaginal secretions. Measurement of lactate production from pyruvate
and NADH at pH 6-8-7-2 would have trebled the activity according to the data of
Neilands (1955), so thatthe LDHactivity ofnormal cervix is approximately 12-fold
that of ICDH and 45-fold that of PGDH when all three are considered from the
standpoint ofoptimal conditions.
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The increased ICDH activity, though significant, was not exceptional. Only
with PGDH was a striking increase in activity found in the carcinomata to an
extent which rendered it unlikely to be due to merely technical considerations.
Indeed the activity of the carcinomata was as high as that of human liver, twice
as high as that of human kidney, and three times as high as that of human heart
and kidney by comparison with the data of Shonk, Koven, Majima and Boxer
(1964). The estimation of this enzyme in vaginal fluid has been proposed as a
diagnostic test for gynaecological cancer (Bonham and Gibbs, 1962), but recent
reports have cast doubt on the merit ofthis procedure (Muir, Canti and Williams,
1964; Cameron and Husain, 1965).
It is clearly not possible to deduce the relative contribution to energy
metabolism provided by glycolytic, respiratory, and direct oxidative mechanism
merely by measurement of a single enzyme from each pathway. All that can
be said for the present is that the increased activity of PGDH in the cancers
is compatible with increased production of pentose sugars for nucleic acid
synthesis. However, the increased levels in the cancers of ICDH and PGDH,
both of which generate NADPH, when set alongside the failure of LDH which
generates NADH to show similar increase, are of interest, since this provides a
link between energy metabolism and synthesis of thymidine as suggested by
Potter (1956).
The particulate activity
Although LDH is generally regarded as a supernatant enzyme (de Duve,
Wattiaux and Baudhuin, 1962), claims have been made for its presence in mito-
chondria (Hess, Scarpelli and Pearse, 1958) and microsomes (Novikoff, 1961).
The finding of LDH in cytoplasmic particles is considered by some workers to be
an artefact associated with media oflow ionic strength (Paigen and Wenner, 1962;
Keck and Choules, 1962). Such a criticism is applicable to the present work.
There is good evidence for the presence ofICDH in liver mitochondria (Hogeboom
and Schneider, 1950; Shepherd, 1961). Although the concensus of most investi-
gators favours the view that PGDH is confined to the supernatant (de Duve, et al.,
1962) it has been reported in particulate fractions ofguinea-pig brain, but requires
to be separated from the membranes of these organelles before activity can be
demonstrated (Yamada and Shimazono, 1961). The effect of ultrasonic disinte-
gration would be similar to that of detergent as used by Yamada and Shimazono
(1961), but partial reoxidation of TPNH by other respiratory enzymes cannot be
ruled out under our conditions, so that our estimates of PGDH activity in the
particle fractions probably err by being too low, and this criticism may also apply
to the other dehydrogenases.
The low particulate activities found in the cancer tissues when compared with
the relatively high activities of the supernatant are compatible with enzyme
adsorption. When consideration is given to the virtual impossibility of detecting
these enzymes in particulate fractions from normal tissue, it seems likely that this
difference is best explained by physico-chemical alterations in particle membranes
arising during malignant transformation, a suggestion rendered plausible by the
report that morphological differences between mitochondria of normal and
malignant cervix uteri can be recognised under the electron microscope (Luibel,
Sanders and Ashworth, 1960). This morphological difference may, however, be
reflected by differences in true enzyme content. A possible, but unlikely,
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explanation is that reoxidation exceeded the rate of production of reduced
nucleotides by dehydrogenases in the normal but not in the malignant particulate
fractions. For the present, an unequivocal choice between adsorptiont and
genuine par-ticulate content of these dehydrogenases in the cancer tissue's cannot
be made.
SUMMARY
The activities of lactate dehydrogenase (LDH), isocitrate dehydrogenase
(ICDH), and phosphogluconate dehydrogenase (PGDH) were measured in cyto-
plasmic fractions prepared from samples of malignant and non-malignant human
cervix uteri.
Relative to protein content and tissue weight, the activities of ICDH and
PGDH were significantly higher in the supernatant fraction ofthe cancer specimens
than in the corresponding fraction ofthe non-malignant specimens. LDH activity
was not significantly higher in the cancer specimens.
The activities of all three dehydrogenases in the mitochondrial and microsomal
fractions of the cancer specimens were similar, the only significant difference
occurring with LDH which was raised relative to protein in the microsomal
fraction. Where particulate fractions from normal samples were suitable for
analysis, no dehydrogenase activity could be detected. More than 9500 of the
total cytoplasmic activity ofeach dehydrogenase in the cancer samples was found
in the supernatant, and it is uncertain whether the activities measured in the
particulate fractions were due to intrinsic content or to enzyme adsorption.
We should like to express our appreciation to Dr. Mary Cowell and Dr. J.
MacVicar who provided the majority of the specimens upon which this report is
based. Our thanks are also due to Dr. E. B. Hendry who allowed us generous
facilities for this work, Professor D. F. Cappell who permitted the use ofequipment
within his department, and Professor J. N. Davidson, F.R.S. and Dr. R. Y.
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